African American living-kidney donors should be screened for apol1 risk alleles

David Cohen, Anuja Mittalhenkle, David Scott, Carlton J. Young, Douglas Norman

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The adjusted rate of end-stage kidney disease (ESKD) among African Americans is markedly increased relative to European Americans. African Americans are overrepresented on the kidney transplantation waiting list and experience longer wait times. In aggregate, these pressures drive recommendations for living donor transplantation. Genovese et al. recently implicated the APOL1 gene in ESKD risk among African Americans (Genovese et al. Science 2010; 329: 841). The presence of two APOL1 risk alleles doubles the relative risk for ESKD; moreover, the alleles are prevalent among African Americans. We propose a strategy for screening for the presence of APOL1 risk alleles among African American living kidney donors and for living-related donors for African American recipients.

Original languageEnglish (US)
Pages (from-to)722-725
Number of pages4
JournalTransplantation
Volume92
Issue number7
DOIs
StatePublished - Oct 15 2011

Fingerprint

Living Donors
African Americans
Alleles
Kidney
Chronic Kidney Failure
Waiting Lists
Kidney Transplantation
Transplantation
Pressure
Genes

Keywords

  • Allele
  • Genetics
  • Kidney

ASJC Scopus subject areas

  • Transplantation

Cite this

African American living-kidney donors should be screened for apol1 risk alleles. / Cohen, David; Mittalhenkle, Anuja; Scott, David; Young, Carlton J.; Norman, Douglas.

In: Transplantation, Vol. 92, No. 7, 15.10.2011, p. 722-725.

Research output: Contribution to journalArticle

@article{ce89a2d67da94b1a8b2afcd4a2446a33,
title = "African American living-kidney donors should be screened for apol1 risk alleles",
abstract = "The adjusted rate of end-stage kidney disease (ESKD) among African Americans is markedly increased relative to European Americans. African Americans are overrepresented on the kidney transplantation waiting list and experience longer wait times. In aggregate, these pressures drive recommendations for living donor transplantation. Genovese et al. recently implicated the APOL1 gene in ESKD risk among African Americans (Genovese et al. Science 2010; 329: 841). The presence of two APOL1 risk alleles doubles the relative risk for ESKD; moreover, the alleles are prevalent among African Americans. We propose a strategy for screening for the presence of APOL1 risk alleles among African American living kidney donors and for living-related donors for African American recipients.",
keywords = "Allele, Genetics, Kidney",
author = "David Cohen and Anuja Mittalhenkle and David Scott and Young, {Carlton J.} and Douglas Norman",
year = "2011",
month = "10",
day = "15",
doi = "10.1097/TP.0b013e31822eec39",
language = "English (US)",
volume = "92",
pages = "722--725",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - African American living-kidney donors should be screened for apol1 risk alleles

AU - Cohen, David

AU - Mittalhenkle, Anuja

AU - Scott, David

AU - Young, Carlton J.

AU - Norman, Douglas

PY - 2011/10/15

Y1 - 2011/10/15

N2 - The adjusted rate of end-stage kidney disease (ESKD) among African Americans is markedly increased relative to European Americans. African Americans are overrepresented on the kidney transplantation waiting list and experience longer wait times. In aggregate, these pressures drive recommendations for living donor transplantation. Genovese et al. recently implicated the APOL1 gene in ESKD risk among African Americans (Genovese et al. Science 2010; 329: 841). The presence of two APOL1 risk alleles doubles the relative risk for ESKD; moreover, the alleles are prevalent among African Americans. We propose a strategy for screening for the presence of APOL1 risk alleles among African American living kidney donors and for living-related donors for African American recipients.

AB - The adjusted rate of end-stage kidney disease (ESKD) among African Americans is markedly increased relative to European Americans. African Americans are overrepresented on the kidney transplantation waiting list and experience longer wait times. In aggregate, these pressures drive recommendations for living donor transplantation. Genovese et al. recently implicated the APOL1 gene in ESKD risk among African Americans (Genovese et al. Science 2010; 329: 841). The presence of two APOL1 risk alleles doubles the relative risk for ESKD; moreover, the alleles are prevalent among African Americans. We propose a strategy for screening for the presence of APOL1 risk alleles among African American living kidney donors and for living-related donors for African American recipients.

KW - Allele

KW - Genetics

KW - Kidney

UR - http://www.scopus.com/inward/record.url?scp=80053316322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053316322&partnerID=8YFLogxK

U2 - 10.1097/TP.0b013e31822eec39

DO - 10.1097/TP.0b013e31822eec39

M3 - Article

C2 - 21878839

AN - SCOPUS:80053316322

VL - 92

SP - 722

EP - 725

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 7

ER -